Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis

BACKGROUND: Skin barrier dysfunction plays a key role in atopic dermatitis (AD). This impairment is related to altered composition and metabolism of epidermal sphingolipids and a deficiency of ceramides. Glycosaminoglycans (GAGs), and especially hyaluronic acid, could be useful in the management of...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsella, Rosanna, Segarra, Sergi, Ahrens, Kim, Alonso, Cristina, Ferrer, Lluís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082980/
https://www.ncbi.nlm.nih.gov/pubmed/32197613
http://dx.doi.org/10.1186/s12917-020-02306-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082980/
https://www.ncbi.nlm.nih.gov/pubmed/32197613
http://dx.doi.org/10.1186/s12917-020-02306-6

Ejemplares similares